Surrogate Advertising and Endorser Accountability: Navigating India’s Regulatory Framework

After Reading This Article You Can Solve This UPSC Mains Model Question:

“Examine the legal mechanisms to tackle surrogate advertising in India and analyze the responsibilities of brand endorsers under the Consumer Protection Act, 2019.” 15 Marks (GS-2 GS – Governance)

Context

The Maharashtra Food and Drug Administration (FDA) issued show-cause notices against promotional campaigns that indirectly market prohibited gutkha and tobacco products through brand extensions, intensifying regulatory scrutiny under the Food Safety and Standards Act, 2006 and Central Consumer Protection Authority (CCPA) norms.

Introduction

Surrogate advertising is a sophisticated circumvention mechanism where prohibited commodities are indirectly promoted through permissible brand extensions. Enhanced statutory oversight by the Central Consumer Protection Authority (CCPA) and State Food Safety Directorates now strictly enforces accountability across manufacturers and brand endorsers to uphold public health.

What is Surrogate Advertising and its Statutory Framework?

• Definition: As delineated in the CCPA Guidelines, 2022, it is the deliberate promotion of legally restricted goods under the guise of permissible products, utilizing identical brand architecture, logos, and taglines to bypass marketing bans and maintain brand recall.
• Prohibitory Powers under the FSS Act, 2006: Section 30(2)(a) empowers the Commissioner of Food Safety to legally prohibit the manufacture, distribution, and sale of hazardous food articles detrimental to public health.
• Penalties for Deceptive Claims (FSS Act, 2006): Sections 24 and 53 explicitly prohibit unfair or misleading food advertisements, penalizing any entity party to the publication of such claims with fines of up to ₹10 lakh.
• Misleading Advertisements Classification: Section 2(28) of the Consumer Protection Act, 2019 legally classifies advertisements that conceal material information, convey false guarantees, or engage in unfair trade practices as misleading.
• CCPA Adjudicatory Authority: Section 21 of the Consumer Protection Act, 2019 authorizes the CCPA to levy punitive financial penalties ranging from ₹10 lakh to ₹50 lakh and legally debar non-compliant brand endorsers for one to three years.
• Constitutional Dynamics: The regulatory landscape balances the commercial freedom to market lawful brand extensions under Article 19(1)(g) against the State’s fundamental constitutional duty to protect public health and nutrition under Article 47.

Significance

1. Protects Public Health: Reinforces statutory bans against carcinogenic substances by curbing subliminal consumer exposure.
2. Enforces Endorser Accountability: Mandates strict pre-endorsement due diligence, ensuring prominent personalities verify claims before lending credibility.
3. Upholds Consumer Rights: Protects the consumer’s right to be informed and shielded against unfair trade practices.
4. Levels Market Competition: Prevents manufacturers of restricted goods from gaining an unfair commercial advantage.
5. Strengthens Inter-Agency Synergy: Promotes coordinated enforcement across the CCPA, Ministry of Health, and State FDAs.

Challenges in Curbing Surrogate Advertising

1. Ambiguity of Brand Extensions: Legitimate manufacturing of non-tobacco consumer items creates legal hurdles in proving deceptive surrogate intent.
2. Constitutional Protections: Businesses frequently invoke Article 19(1)(g) to defend advertising legally permitted goods sharing a parent brand.
3. Evidentiary Complexities: Establishing cross-subsidization between permitted and banned variants requires complex financial audits.
4. Decentralized Digital Media: Rapid propagation of promotional campaigns online complicates real-time monitoring and enforcement.
5. Fragmented Jurisdiction: Overlapping mandates across COTPA (2003), the FSS Act (2006), and the Consumer Protection Act (2019) create procedural bottlenecks.

Way Forward

1. Establish Independent Turnover Criteria: Restrict brand extension advertising exclusively to products demonstrating substantial, independent sales volumes.
2. Mandate Visual Segregation: Enforce distinct packaging, separate brand logos, and unique color themes for permitted items.
3. Institutionalize Mandatory Due Diligence: Require brand endorsers to maintain verifiable proof of product background checks before contracting.
4. Harmonize Multi-Agency Frameworks: Integrate enforcement mechanisms of the CCPA, FSSAI, and State Food Safety Commissions under a unified portal.
5. Impose Stringent Deterrent Penalties: Escalate financial penalties for repeat corporate offenders circumventing statutory bans.
6. Deploy AI Regulatory Surveillance: Utilize automated tools to detect misleading surrogate campaigns on digital media platforms.

Conclusion

Eradicating surrogate advertising is imperative to protect public welfare and ensure fair trade. A cohesive strategy combining regulatory harmonization and strict endorser due diligence will dismantle deceptive marketing and fulfill constitutional health mandates.

Important CTC From This Article For UPSC Central Consumer Protection Authority (CCPA)